Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection.
Andrew LeberRaquel HontecillasVida AbediNuria Tubau-JuniVictoria Zoccoli-RodriguezCaroline StewartJosep Bassaganya-RieraPublished in: Artif. Intell. Medicine (2017)